Page last updated: 2024-08-25

bendamustine hydrochloride and Benign Monoclonal Gammopathies

bendamustine hydrochloride has been researched along with Benign Monoclonal Gammopathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, Y; Lin, X; Xu, Q; Yu, J; Zhang, K1
Fornecker, LM; Lipsker, D; Martin, M; Martin, T; Toussaint, E1

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Benign Monoclonal Gammopathies

ArticleYear
CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.
    Medicine, 2021, Nov-24, Volume: 100, Issue:47

    Topics: Aged; Anemia; Antineoplastic Agents; Bendamustine Hydrochloride; Bortezomib; Dexamethasone; Humans; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Monoclonal Gammopathy of Undetermined Significance; Red-Cell Aplasia, Pure; Rituximab; Sirolimus

2021
Bendamustine conditioning for refractory type I cryoglobulinemia.
    Joint bone spine, 2016, Volume: 83, Issue:5

    Topics: Adult; Antineoplastic Agents, Alkylating; Autografts; Bendamustine Hydrochloride; Cryoglobulinemia; Female; Humans; Monoclonal Gammopathy of Undetermined Significance; Stem Cell Transplantation

2016